S

Sun Pharma Advanced Research Co Ltd
NSE:SPARC

Watchlist Manager
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Watchlist
Price: 158.84 INR -0.29% Market Closed
Market Cap: 51.5B INR

Relative Value

The Relative Value of one SPARC stock under the Base Case scenario is 8.02 INR. Compared to the current market price of 158.84 INR, Sun Pharma Advanced Research Co Ltd is Overvalued by 95%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SPARC Relative Value
Base Case
8.02 INR
Overvaluation 95%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
4
Median 3Y
59.7
Median 5Y
47.2
Industry
2.5
Forward
0.1
vs History
vs Industry
Median 3Y
-25.2
Median 5Y
-26.6
Industry
21.8
Forward
2.8
vs History
vs Industry
Median 3Y
-29.2
Median 5Y
-29.3
Industry
16.6
vs History
vs Industry
Median 3Y
-27.2
Median 5Y
-27.1
Industry
24
vs History
vs Industry
1
Median 3Y
12.3
Median 5Y
-21.9
Industry
2.1
vs History
30
vs Industry
3
Median 3Y
61.1
Median 5Y
48.5
Industry
2.7
Forward
0.1
vs History
28
vs Industry
1
Median 3Y
102.7
Median 5Y
58.1
Industry
5.3
vs History
vs Industry
Median 3Y
-26.5
Median 5Y
-28.2
Industry
12.8
Forward
0.3
vs History
vs Industry
Median 3Y
-25.4
Median 5Y
-26.8
Industry
16.2
Forward
0.4
vs History
vs Industry
Median 3Y
-29.2
Median 5Y
-30.2
Industry
15.1
vs History
vs Industry
Median 3Y
-25.3
Median 5Y
-27.2
Industry
17.7
vs History
87
vs Industry
3
Median 3Y
36.2
Median 5Y
44.1
Industry
1.9

Multiples Across Competitors

SPARC Competitors Multiples
Sun Pharma Advanced Research Co Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
51.5B INR 71.8 -15 -16.8 -16.1
US
Eli Lilly and Co
NYSE:LLY
739.9B USD 15.1 66.6 35.8 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
375.3B USD 4.2 17.2 12.6 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 6.6 19.1 13.3 15.2
CH
Roche Holding AG
SIX:ROG
206.8B CHF 3.4 25 9.4 11
CH
Novartis AG
SIX:NOVN
192.2B CHF 4.5 18.8 11.1 14.8
UK
AstraZeneca PLC
LSE:AZN
160.3B GBP 4 28.2 130.8 197.2
US
Merck & Co Inc
NYSE:MRK
203.6B USD 3.2 11.7 8.7 10.5
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
144.3B USD 2.3 18.3 7.8 10.9
P/E Multiple
Earnings Growth PEG
IN
S
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Average P/E: 25.6
Negative Multiple: -15
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
66.6
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.2
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
19.1
18%
1.1
CH
Roche Holding AG
SIX:ROG
25
32%
0.8
CH
Novartis AG
SIX:NOVN
18.8
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.2
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.7
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
18.3
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
S
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Average EV/EBITDA: 433.7
Negative Multiple: -16.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.8
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.6
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
13%
1
CH
Roche Holding AG
SIX:ROG
9.4
5%
1.9
CH
Novartis AG
SIX:NOVN
11.1
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
130.8
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.7
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.8
2%
3.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
S
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Average EV/EBIT: 1 867.3
Negative Multiple: -16.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.1
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
15.2
14%
1.1
CH
Roche Holding AG
SIX:ROG
11
6%
1.8
CH
Novartis AG
SIX:NOVN
14.8
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197.2
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.5
11%
1
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.9
10%
1.1